SCHEMBL1032628

SCHEMBL1032628

CCCNCCOc1ccc(NS(=O)(=O)c2ccc(C(C)C)cc2)c(OC)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.39
CYP2C9 P11712 1/20 0.39
EDNRB P24530 1/20 0.38
EDNRA P25101 1/20 0.38
LMNA P02545 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
TSHR P16473 2/20 0.37
HTT P42858 2/20 0.37
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
KCNH2 Q12809 1/20 0.36
CCR9 P51686 1/20 0.36
HIF1A Q16665 1/20 0.36
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
CCR2 P41597 1/20 0.35
CCR4 P51679 1/20 0.35
SCN9A Q15858 1/20 0.35
TRPV1 Q8NER1 4/20 0.34
SQSTM1 Q13501 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4240630 0.99 CYP2C9 (0.39) CYP2C19CYP2C9EDNRBEDNRALMNA
SCHEMBL1031352 0.91 LMNA (0.35) CYP2C19CYP2C9EDNRBEDNRALMNA
SCHEMBL1032277 0.91 LMNA (0.35) CYP2C19CYP2C9EDNRBEDNRALMNA
SCHEMBL4045301 0.91 LMNA (0.35) CYP2C19CYP2C9EDNRBEDNRALMNA
Hydrochloric Acid SCHEMBL4249141 0.91 LMNA (0.35) CYP2C19CYP2C9LMNASMN1; SMN2TSHR
SCHEMBL1027217 0.91 LMNA (0.35) CYP2C19CYP2C9EDNRBEDNRALMNA
Hydrochloric Acid SCHEMBL4249120 0.91 LMNA (0.35) CYP2C19CYP2C9LMNASMN1; SMN2TSHR
SCHEMBL1031793 0.91 LMNA (0.35) CYP2C19CYP2C9EDNRBEDNRALMNA
SCHEMBL1031114 0.90 TRPV1 (0.37) EDNRBEDNRALMNASMN1; SMN2TSHR
Hydrochloric Acid SCHEMBL4244120 0.90 LMNA (0.34) CYP2C19CYP2C9EDNRBEDNRALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013179-B1 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO KG (DE) 2011-01-19 EP disclosed